ID: MRFR/PNT/5724-CR | February 2020 | Region: Global | 170 pages
Temperature-controlled packaging for pharmaceutical market is set to increase at 9.48% CAGR between 2020 and 2027.
Investment in pharmaceutical packaging has spiraled upwards, signaling towards a favorable status for the market during the projected future. Growing demand for effective packaging solutions in the pharmaceutical industry is primarily driving the market’s growth. In addition, players are likely to find tremendous opportunities in emerging markets over the next several years.
This MRFR report offers a detailed analysis of the global temperature-controlled packaging for pharmaceutical market. It also includes a Seven-Year (2020-2027) revenue projection. The report covers historical growth, industry trends and opportunities, market restraints and growth drivers. Further a descriptive segmental study of the market based on different temperature-controlled packaging products is also available in the report.
Historical market trends, market dynamics, forecast, market value by region as well as by segmentation, country-level analysis for each market segment, key player’s market share analysis and market factor analysis which covers supply chain and Porter’s five forces analysis of the market.
Envirotainer AB, Cold Chain Technologies, Sofrigam, Pelican Bio Thermal, Sonoco ThermoSafe, Softbox Systems Limited, va-Q-tec AG, Storopack Hans Reichenecker GmbH, DHL International GmbH, DB Schenker, United Parcel Service of America, Inc. (UPS), and KUEHNE + NAGEL INC.
Market Research Future (MRFR) employs a multi-layered statistical solution for the analysis of critical market elements to garner highly accurate insights. The advanced data triangulation technique aids in conducting extensive qualitative and quantitative analysis of macroeconomic indicators and governing factors of market such as historical trends, key market dynamics, consumer landscape, possible disruptions, and growth opportunities. Primary and secondary research processes ensure the authenticity and objectivity of the research findings. Primary research process aids in collection of data by conducting one-on-one interviews with key opinion holders across the value chain and undertaking detailed surveys. Secondary research module is utilized for verifying the collected data through inputs from existing industry documentations such as whitepapers, paid databases, annual reports, SEC filings and others. In addition to this, top-down and bottom-up approaches are utilized for optimum evaluation of research findings.
For the scope of the research, MRFR’s report offers a comprehensive segmental analysis of the global market for temperature-controlled packaging for pharmaceutical
By Temperature Range
By Payload Capacity
By Type of Use
By End-Use Industry
|Market Size||2027: Significant Value|
|CAGR||9.48% CAGR (2020-2027)|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Type, Temperature Range, Payload Capacity, Type of Use, End-Use Industry|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Envirotainer AB, Cold Chain Technologies, Sofrigam, Pelican Bio Thermal, Sonoco ThermoSafe, Softbox Systems Limited, va-Q-tec AG, Storopack Hans Reichenecker GmbH, DHL International GmbH, DB Schenker, United Parcel Service of America, Inc. (UPS), and KUEHNE + NAGEL INC.|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The temperature controlled packaging for pharmaceutical market is supposed to register 9.48% CAGR.
The major players are Sonoco ThermoSafe, DB Schenker, Sofrigam, United Parcel Service of America, Inc. (UPS), Softbox Systems Limited, Cold Chain Technologies, Storopack Hans Reichenecker GmbH, KUEHNE + NAGEL INC, Envirotainer AB, DHL International GmbH, Pelican Bio Thermal, and va-Q-tec AG.
The segments of the temperature controlled packaging for pharmaceutical market, by payload capacity, are Up to 10 L, 20-40 L, 10-20 L, 40-150 L, and More than 150 L.
The up to 10 L segment is anticipated to expand at 9.53% CAGR.
The 40-150 L segment is anticipated to mark 9.88% CAGR.
The segments based on end-use industry are pharmaceutical and clinical trial.
The global temperature-controlled packaging for pharmaceutical market is projected to witness a compound annual growth rate of 9.48% during the assessment period (2020-2027). In the pharmaceutical sector, need for effective packaging solutions is more than ever before. Introduction of highly sensitive drugs has necessitated the development of dynamic packaging systems such as temperature-controlled packaging. These packaging systems are purpose-built and have a larger application bandwidth as compared to traditional packaging solutions.
Temperature is one of the most important areas of focus in pharmaceutical packaging, as it can have a severe impact on efficacy of drugs, worse, change their physical nature. To tackle such issues, temperature-controlled packaging solutions are preferred. Such factors are driving the popularity of temperature-controlled packaging in the pharmaceutical sector. The global temperature-controlled packaging for pharmaceutical market has grown at an impressive rate in recent years. Growing investment in R&D and rapid adoption of next-generation cold chain technologies are other factors that are providing an impetus to the market. Also, emphasis is being placed on product innovation and expanding product portfolio. Demand for temperature control packaging solutions that can maintain the required temperature of products even in extreme conditions in on the rise, which is reflecting favorably on the market. In addition, lucrative opportunities in emerging markets across regions such as Asia Pacific, Latin America and Middle East indicate towards an optimistic future for stakeholders.
The segmental analysis of the market is conducted on the basis of product, type, temperature range, payload capacity, type of use, end-use industry, and region.
By product, the market has been segmented as insulated shippers and insulated containers. The insulated shippers segment currently accounts for more than 62% market share. In 2017, the segment stood at a valuation of USD 3,172.3 Mn and is projected to capture a CAGR of 9.26% during the assessment period. This is owing to the rising investment in insulated packaging solution as they offer effective packaging for temperature sensitive products. Insulated shippers are lightweight and versatile in nature.
By type, the market has been segmented into active systems and passive systems. The active systems segment holds the lion’s share of the market. The segment is expected to remain highly attractive over the next couple of years. By the year 2023, the active systems segment is projected to surpass a market valuation of USD 5,000 Mn. Active systems are leased containers with innovative temperature control systems powered by electricity. They are secure, eco-friendly, and facilitate quick loading/ unloading.
By temperature range, the market has been segmented into Up to 10°C, 10°C to 20°C and more than 20°C. The up to 10°C segment accounted for 48.20% share of the market in 2017. The segment is projected to surge at a CAGR of 9.93% during the forecast period. This is owing to increasing usage of packaging solutions with temperature range of up to 10°C in high-risk products such as vaccines, insulins, blood products (such as Factor VIII) and other proteinaceous materials.
Based on payload capacity, the market has been segmented into up to 10 L, 10-20 L, 20-40 L, 40-150 L, and more than 150 L. The up to 10 L segment currently accounts for the largest market and is expected to remain highly profitable in 2019 and beyond. The segment is expected to reach a market valuation of over USD 2,600 Mn.
Based on type of use, the market has been segmented into single use and reusable. The single-use segment holds the pole position. In 2017, the segment accounted for more than two-third market share.
Based on end-use industry, the market has been segmented into pharmaceutical and clinical trial. The former will continue to outperform the later throughout the assessment period. In 2017, the pharmaceutical segment reached a valuation in excess of USD 4,000 Mn.
The market has been covered across regions such as North America, Latin America, the Middle East & Africa (MEA), Europe and Asia Pacific (APAC). North America is one of the prominent markets for the temperature-controlled packaging for pharmaceutical products. Presence of a favorable investment climate along with the existence of a massive pharmaceutical sector is supporting the growth of the market in the region. Other factors such as stringent pharmaceutical products safety policies and rising geriatric population is creating opportunities for companies operating in the region. North America is followed by Asia-Pacific, and Europe respectively.
Cold Chain Technologies, Envirotainer AB, Pelican Bio Thermal, Sofrigam, Softbox Systems Limited, Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, va-Q-tec AG, DB Schenker, DHL International GmbH, KUEHNE + NAGEL INC, and United Parcel Service of America, Inc. (UPS) are among the leading companies operating in the global temperature-controlled packaging for pharmaceutical market.
Global Temperature-controlled Packaging for Pharmaceutical Market- Competitive Landscape
Market Research Future includes following key players for global Temperature-controlled Packaging for Pharmaceutical Market research study: Envirotainer AB, Pelican Biothermal LLC, Sofrigam, Softbox Systems Limited, Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, and Va-Q-Tec AG and the major logistic companies are DHL International GmbH, Yusen Logistics, Agility, CEVA logistics, DB Schenker, DHL International GmbH, and KUEHNE + NAGEL INC.
The market share analysis is derived by considering various factors such as financial position, segmental R&D investment, product innovations, corporate strength, product portfolio, strategy analysis, and, key innovations in the market among other factors. The major players holding prominent position in the Market are Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, Envirotainer AB, Cold Chain Technologies, and Softbox Systems Ltd. among others.
According to MRFR analysis, Sonoco ThermoSafe is a global giant in temperature assurance packaging for efficient and safe transportation of pharmaceuticals, vaccines, and other temperature sensitive products with 5.2% market share. The company has broad portfolio for other products such as insulated slippers, durable insulated containers, protective packaging and diagnostic. The company has 30 global location (15 ThermoSafe dedicated and 15 Sonoco Protective solution), out of which more than 50 plant sites are in Southeast Asia and 8 sites are in China. The company believes that cash generated from operations will help focus on the development of new products, and new markets, as well as it will help gain customers.
Storopack Hans Reichenecker GmbH is the second largest company offering nnovative and effective packaging solutions with 3.8% of the total market share. The company has a wide line of offerings, which include flexible protective packaging, temperature controlled protective packaging, customized protective packaging, technical molded parts, which are applicable in automotive, consumer electronics, industry, food, and pharmaceutical industries. It is continuously working on the challenges encountered while offering appropriate solutions and the highest level of services for changing demands of customers.
Envirotainer AB holds the third largest market share of the market with 2.5%. The company develops and manufactures innovative containers, including validation and testing, services for pharmaceutical products, which require for temperature controlled packaging. It offers services such as the active cold chain containers, and cold chain services which include various subsegments such as technical support, post-shipment analysis, qualification services, shipment set up services, and active cold chain membership. The company focuses on forming partnerships and increasing the number of warehouses based on demand and sales in various regions to gain the maximum number of customers.
Cold Chain Technologies (CCT) holds the fourth largest market share with 0.7% of the global market. It offers a wide range of cost-effective packaging options for Just in Time (JIT) delivery to the customers. The company includes, standard and custom KoolTemp qualified shipping systems and containers, Koolit refrigerants and PCMs and temperature indicators and loggers. It’s extensive thermal packaging design and manufacturing experience enables it to provide quality focused products and services to clients around the world in markets that include pharmaceutical and biotech manufacturers, third-party logistic (3PL) providers, and specialty pharmacies.
Softbox Systems Ltd. holds 0.4% of the global market share. The company is involved in the design, development, and production of passive temperature-controlled packaging systems for pharmaceutical companies. Recently, company has made a number of acquisitions of major companies such as Cold Tech Systems, TP3 Global, and Tempack. This will strengthen its portfolio in the future.